The Food & Drug Administration cleared Aesculap Implant Systems LLC’s S4 cervical occipital plating system.
The Center Valley, Pa.-based company received a "substantial equivalence" determination for its Special 510(k) application for the spinal injury treatment system seven months after the FDA began its review of the device, according to the company.